Cargando…
High Levels of Frataxin Overexpression Lead to Mitochondrial and Cardiac Toxicity in Mouse Models
Friedreich ataxia (FA) is currently an incurable inherited mitochondrial disease caused by reduced levels of frataxin (FXN). Cardiac dysfunction is the main cause of premature death in FA. Adeno-associated virus (AAV)-mediated gene therapy constitutes a promising approach for FA, as demonstrated in...
Autores principales: | Belbellaa, Brahim, Reutenauer, Laurence, Messaddeq, Nadia, Monassier, Laurent, Puccio, Hélène |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Gene & Cell Therapy
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7648087/ https://www.ncbi.nlm.nih.gov/pubmed/33209958 http://dx.doi.org/10.1016/j.omtm.2020.08.018 |
Ejemplares similares
-
The First Cellular Models Based on Frataxin Missense Mutations That Reproduce Spontaneously the Defects Associated with Friedreich Ataxia
por: Calmels, Nadège, et al.
Publicado: (2009) -
Comparative multi-omic analyses of cardiac mitochondrial stress in three mouse models of frataxin deficiency
por: Sayles, Nicole M., et al.
Publicado: (2023) -
Limitations in a frataxin knockdown cell model for Friedreich ataxia in a high-throughput drug screen
por: Calmels, Nadège, et al.
Publicado: (2009) -
Mammalian Frataxin: An Essential Function for Cellular Viability through an Interaction with a Preformed ISCU/NFS1/ISD11 Iron-Sulfur Assembly Complex
por: Schmucker, Stéphane, et al.
Publicado: (2011) -
In vivo overexpression of frataxin causes toxicity mediated by iron-sulfur cluster deficiency
por: Huichalaf, Claudia, et al.
Publicado: (2022)